Back

Dimethylarginine dimethylaminohydrolase-1 (DDAH-1) inhibition by proton pump inhibitors: in vitro and in vivo significance

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Metabolism and hypertrophy Metabolism and metabolic syndromes ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Sara Tommasi

Flinders Medical Centre, Bedford Park (Australia)

15 More presentations in this session

Presentation thumbnail
SorLA is a novel high affinity PCSK9 receptor that inhibits its inactivation by furin
Assistant Professor C. Gustafsen (Aarhus, DK)
Abstract
Presentation thumbnail
Impact of epicardial adipose tissue in the cardiac structure
Miss G. Conceicao (Porto, PT)
Abstract
Presentation thumbnail
The pathological role of gamma-aminobutyric acid (GABA) signaling in inducing brown adipose tissue dysfunction in obesity.
Doctor R. Ikegami (Niigata, JP)
Abstract
Presentation thumbnail
Metabolic alterations derived from the absence of Two-Pore Channel 1 (TPCN1) at cardiac level.
Doctor S. Feijoo-Bandin (Santiago de Compostela, ES)
Abstract Slides
Presentation thumbnail
Vascular senescence-messaging secretome disrupts metabolic function of mature adipocytes
Doctor A. Barinda (Kobe, JP)
Abstract Slides

Access the full session

Session thumbnail
Poster session 2 - Metabolism and hypertrophy

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources